查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945472

2026年全球左心室辅助装置市场报告

Left Ventricular Assist Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，左心室辅助装置市场显着扩张，预计将从2025年的17.3亿美元成长到2026年的19亿美元，复合年增长率达9.7%。过去几年的增长可归因于多种因素，包括晚期心臟衰竭患者数量的增加、供体心臟供不应求、专业心臟护理中心的扩张、外科移植技术的改进以及机械循环辅助装置在临床上的接受度不断提高。

预计未来几年，左心室辅助装置（LVAD）市场将快速成长，到2030年市场规模将达到27.8亿美元，复合年增长率（CAGR）为10.0%。预测期内的成长要素包括：患有心臟病的老年人口不断增长、对长期心臟衰竭管理解决方案的需求不断增长、生物相容性材料的进步、远端监测技术的日益普及以及LVAD报销范围的扩大。预测期内的主要趋势包括：连续流LVAD的普及率不断提高、LVAD作为最后治疗手段的应用日益广泛、对小型化植入式泵的关注度不断提升、远端患者监护能力的增强以及对装置耐用性和使用寿命的日益重视。

预计未来医疗费用支出的成长将推动左心室辅助装置市场的发展。医疗费用支出涵盖所有与医疗服务、计划生育、营养计划和以健康为中心的紧急援助相关的费用。医疗费用支出的成长推动了包括左心室辅助装置在内的各种医疗保健相关产品的进步和发展。预计医疗费用支出的成长将对左心室辅助装置市场的成长产生积极影响。例如，根据美国医疗保险和医疗补助服务中心 (CMS) 于 2025 年 6 月发布的数据，到 2023 年，全国医疗保健支出将成长 7.5%，达到 4.9 兆美元，占美国国内生产总值(GDP) 的 17.6%。因此，医疗保健支出的成长正在推动左心室辅助装置市场的成长。

左心室辅助装置领域的企业正致力于开发下一代技术，以取代传统的旋转式左心室辅助装置（LVAD），尤其是基于波膜的系统。波膜解决方案旨在模拟天然心臟的搏动性和血流动力学，从而有可能复製健康心臟的功能，并减少与连续流装置相关的併发症。例如，2025年9月，总部位于法国的医疗设备製造商CorWave SA在雪梨圣文森特医院成功为首例病患植入了其左心室辅助系统（LVAS）。该系统透过有效减轻左心室负荷，同时维持25.5 ± 6.1 mmHg的主动脉脉压，实现了完全的心臟支持，从而确保了主动脉瓣的稳定开放。该装置达到了其主要终点，在30天内未发生任何与装置相关的不利事件，患者在接受84天的支持后成功进行了心臟移植手术。这项进展代表了能够提供安全、生理性搏动血流的连续机械循环支援装置领域的重大进步。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球左心室辅助装置市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 数位化、云端运算、巨量资料、网路安全
  • 主要趋势
    • 持续流左心室辅助装置（LVAD）的采用率不断提高
    • 左心室辅助装置（LVAD）作为最后治疗手段的使用日益增多
    • 人们对小型化植入帮浦的兴趣日益浓厚
    • 扩展远端患者监护能力
    • 更加重视设备的耐用性和使用寿命

第五章 终端用户产业市场分析

  • 医院
  • 心臟病中心
  • 心臟诊所
  • 心臟移植中心
  • 高级心臟衰竭诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球左心室辅助装置市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球左心室辅助装置市场规模、对比及成长率分析
  • 全球左心室辅助装置市场表现：规模与成长，2020-2025年
  • 全球左心室辅助装置市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 经皮左心室辅助装置，植入式左心室辅助装置
  • 按流量类型
  • 搏动性和非搏动性
  • 透过使用
  • 復健桥樑疗法 (BTR)、移植桥樑疗法 (BTT)、终末治疗、候选者桥樑疗法 (BTC)
  • 最终用户
  • 心臟病中心，医院
  • 依类型细分：经皮左心室辅助装置
  • 轴流式经皮左心室辅助装置，离心式经皮左心室辅助装置
  • 依类型细分：植入式左心室辅助装置
  • 连续流装置、脉动流装置

第十章 区域与国家分析

  • 全球左心室辅助装置市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球左心室辅助装置市场：依国家、表现及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 左心室辅助装置市场：竞争格局与市场份额，2024 年
  • 左心室辅助装置市场：公司估价矩阵
  • 左心室辅助装置市场：公司概况
    • Abbott Laboratories
    • Medtronic plc
    • Terumo Corporation
    • St. Jude Medical
    • MAQUET GmbH & Co.

第37章：其他领先和创新企业

  • LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年左心室辅助装置市场：提供新机会的国家
  • 2030年左心室辅助装置市场：充满新机会的细分市场
  • 2030年左心室辅助装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MLVAD01_G26Q1

A left ventricular assist device (LVAD) serves as a mechanical pump implanted in heart failure patients, assisting the heart's lower left chamber (left ventricle) in pumping blood to the aorta and throughout the body.

The primary types of left ventricular assist devices include transcutaneous left ventricular assist devices and implantable left ventricular assist devices. A transcutaneous left ventricular assist device is characterized by having both an external power supply and an internal pump located inside the body. Tubes connect the pump to the heart through small openings in the abdomen. This type of LVAD is often employed for short-term support during or following surgery. Left ventricular assist devices can have either pulsatile or non-pulsatile flows, and they are used in various therapeutic approaches such as bridge-to-recovery (BTR) therapy, bridge-to-transplant (BTT) therapy, destination therapy, and bridge-to-candidacy (BTC) therapy. Cardiology centers and hospitals typically utilize these devices for patient care.

Tariffs are impacting the left ventricular assist devices market by increasing costs of imported precision components, biocompatible materials, electronic controllers, and manufacturing equipment used in implantable and transcutaneous LVAD systems. Hospitals and cardiac centers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces higher production costs for export-oriented device manufacturing. These tariffs are increasing device pricing and procurement complexity for healthcare providers. However, they are also encouraging localized manufacturing, regional supplier partnerships, and greater investment in domestic medical device production capabilities.

The left ventricular assist devices market research report is one of a series of new reports from The Business Research Company that provides left ventricular assist devices market statistics, including left ventricular assist devices industry global market size, regional shares, competitors with a left ventricular assist devices market share, detailed left ventricular assist devices market segments, market trends and opportunities, and any further data you may need to thrive in the left ventricular assist devices industry. This left ventricular assist devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The left ventricular assist devices market size has grown strongly in recent years. It will grow from $1.73 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of advanced heart failure, limited availability of donor hearts, expansion of specialized cardiac care centers, improvements in surgical implantation techniques, rising clinical acceptance of mechanical circulatory support.

The left ventricular assist devices market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing aging population with cardiac conditions, rising demand for long-term heart failure management solutions, advancements in biocompatible materials, growing integration of remote monitoring technologies, expanding reimbursement coverage for lvads. Major trends in the forecast period include increasing adoption of continuous flow lvads, rising use of lvads as destination therapy, growing focus on miniaturized implantable pumps, expansion of remote patient monitoring capabilities, enhanced emphasis on device durability and longevity.

The increase in healthcare expenditures is expected to drive the growth of the left ventricular assist device market in the future. Healthcare expenditures encompass all costs related to providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. Higher healthcare spending can facilitate the advancement and development of various health-related products, including left ventricular assist devices. As healthcare expenditures rise, they will positively impact the growth of the left ventricular assist device market. For example, in June 2025, data from the Centers for Medicare & Medicaid Services (CMS), a United States-based federal agency, indicated that national health spending rose by 7.5% in 2023 to reach $4.9 trillion, representing 17.6% of the United States gross domestic product. Thus, the rise in healthcare expenditures is propelling the growth of the left ventricular assist device market.

Companies active in the left ventricular assist devices space are increasingly concentrating on the development of next-generation technologies, including wave membrane-based systems, as alternatives to conventional rotary LVADs. Wave membrane solutions are designed to mimic natural cardiac pulsatility and blood flow dynamics, closely replicating the function of a healthy heart and potentially reducing complications associated with continuous-flow devices.For instance, in September 2025, CorWave SA, a France-based medical device company, successfully performed the first human implantation of its Left Ventricular Assisting System (LVAS) at St Vincent's Hospital in Sydney. The system delivered complete cardiac support by effectively unloading the left ventricle while maintaining an aortic pulse pressure of 25.5 +- 6.1 mmHg and enabling consistent aortic valve opening. The device met its primary study endpoints without any device-related adverse events at 30 days, and the patient subsequently underwent a successful heart transplant after 84 days of support. This development marks a significant advancement in durable mechanical circulatory support through the delivery of safe, physiological pulsatile blood flow.

In March 2025, Abbott Laboratories, a United States-based healthcare technology company, entered into a collaboration agreement with Cadrenal Therapeutics, Inc. for an undisclosed value. Through this partnership, Abbott sought to support Cadrenal in the execution of a pivotal clinical trial evaluating tecarfarin in patients implanted with HeartMate 3(TM) LVADs, thereby strengthening its role in advanced heart failure care and clinical research. Cadrenal Therapeutics, Inc. is a United States-based biopharmaceutical company focused on the development of novel anticoagulant therapies, including tecarfarin, specifically for patients using cardiovascular devices such as left ventricular assist devices.

Major companies operating in the left ventricular assist devices market are Abbott Laboratories, Medtronic plc, Terumo Corporation, St. Jude Medical, MAQUET GmbH & Co., LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc., Leviticus Cardio Ltd., Calon Cardio-Technology Ltd, Evaheart Inc., Sunshine Heart Inc., CH Biomedical Inc.

North America was the largest region in the left ventricular assist devices market in 2025. The regions covered in the left ventricular assist devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the left ventricular assist devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The left ventricular assist devices market consists of sales of rechargeable left ventricular assist devices, non-rechargeable left ventricular assist devices, heart pumps, and controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Left Ventricular Assist Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses left ventricular assist devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for left ventricular assist devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The left ventricular assist devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Percutaneous Left Ventricular Assist Devices; Implantable Left Ventricular Assist Devices
  • 2) By Type Of Flow: Pulsatile; Non-Pulsatile
  • 3) By Application: Bridge-To-Recovery (BTR) Therapy; Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Candidacy (BTC) Therapy
  • 4) By End-User: Cardiology Centers; Hospitals
  • Subsegments:
  • 1) By Percutaneous Left Ventricular Assist Devices: Axial-Flow Percutaneous LVADs; Centrifugal-Flow Percutaneous LVADs
  • 2) By Implantable Left Ventricular Assist Devices: Continuous Flow Devices; Pulsatile Flow Devices
  • Companies Mentioned: Abbott Laboratories; Medtronic plc; Terumo Corporation; St. Jude Medical; MAQUET GmbH & Co.; LivaNova Plc; Thoratec Corporation; Abiomed Inc; Berlin Heart GmbH; BioVentrix; Cleveland Heart Inc.; Jarvik Heart Inc.; CorWave SA; SynCardia Systems LLC; NuPulseCV Inc.; Fineheart; Procyrion Inc; Carmat SA; BiVACOR Inc; Cardiac Assist Inc.; Leviticus Cardio Ltd.; Calon Cardio-Technology Ltd; Evaheart Inc.; Sunshine Heart Inc.; CH Biomedical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Left Ventricular Assist Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Left Ventricular Assist Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Left Ventricular Assist Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Left Ventricular Assist Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Continuous Flow Lvads
    • 4.2.2 Rising Use Of Lvads As Destination Therapy
    • 4.2.3 Growing Focus On Miniaturized Implantable Pumps
    • 4.2.4 Expansion Of Remote Patient Monitoring Capabilities
    • 4.2.5 Enhanced Emphasis On Device Durability And Longevity

5. Left Ventricular Assist Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cardiology Centers
  • 5.3 Cardiac Specialty Clinics
  • 5.4 Heart Transplant Centers
  • 5.5 Advanced Heart Failure Clinics

6. Left Ventricular Assist Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Left Ventricular Assist Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Left Ventricular Assist Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Left Ventricular Assist Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Left Ventricular Assist Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Left Ventricular Assist Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Left Ventricular Assist Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Left Ventricular Assist Devices Market Segmentation

  • 9.1. Global Left Ventricular Assist Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Percutaneous Left Ventricular Assist Devices, Implantable Left Ventricular Assist Devices
  • 9.2. Global Left Ventricular Assist Devices Market, Segmentation By Type Of Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pulsatile, Non-Pulsatile
  • 9.3. Global Left Ventricular Assist Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bridge-To-Recovery (BTR) Therapy, Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy
  • 9.4. Global Left Ventricular Assist Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiology Centers, Hospitals
  • 9.5. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Percutaneous Left Ventricular Assist Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Axial-Flow Percutaneous LVADs, Centrifugal-Flow Percutaneous LVADs
  • 9.6. Global Left Ventricular Assist Devices Market, Sub-Segmentation Of Implantable Left Ventricular Assist Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Flow Devices, Pulsatile Flow Devices

10. Left Ventricular Assist Devices Market Regional And Country Analysis

  • 10.1. Global Left Ventricular Assist Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Left Ventricular Assist Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Left Ventricular Assist Devices Market

  • 11.1. Asia-Pacific Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Left Ventricular Assist Devices Market

  • 12.1. China Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Left Ventricular Assist Devices Market

  • 13.1. India Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Left Ventricular Assist Devices Market

  • 14.1. Japan Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Left Ventricular Assist Devices Market

  • 15.1. Australia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Left Ventricular Assist Devices Market

  • 16.1. Indonesia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Left Ventricular Assist Devices Market

  • 17.1. South Korea Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Left Ventricular Assist Devices Market

  • 18.1. Taiwan Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Left Ventricular Assist Devices Market

  • 19.1. South East Asia Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Left Ventricular Assist Devices Market

  • 20.1. Western Europe Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Left Ventricular Assist Devices Market

  • 21.1. UK Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Left Ventricular Assist Devices Market

  • 22.1. Germany Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Left Ventricular Assist Devices Market

  • 23.1. France Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Left Ventricular Assist Devices Market

  • 24.1. Italy Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Left Ventricular Assist Devices Market

  • 25.1. Spain Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Left Ventricular Assist Devices Market

  • 26.1. Eastern Europe Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Left Ventricular Assist Devices Market

  • 27.1. Russia Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Left Ventricular Assist Devices Market

  • 28.1. North America Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Left Ventricular Assist Devices Market

  • 29.1. USA Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Left Ventricular Assist Devices Market

  • 30.1. Canada Left Ventricular Assist Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Left Ventricular Assist Devices Market

  • 31.1. South America Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Left Ventricular Assist Devices Market

  • 32.1. Brazil Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Left Ventricular Assist Devices Market

  • 33.1. Middle East Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Left Ventricular Assist Devices Market

  • 34.1. Africa Left Ventricular Assist Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Left Ventricular Assist Devices Market, Segmentation By Type, Segmentation By Type Of Flow, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Left Ventricular Assist Devices Market Regulatory and Investment Landscape

36. Left Ventricular Assist Devices Market Competitive Landscape And Company Profiles

  • 36.1. Left Ventricular Assist Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Left Ventricular Assist Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Left Ventricular Assist Devices Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. St. Jude Medical Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. MAQUET GmbH & Co. Overview, Products and Services, Strategy and Financial Analysis

37. Left Ventricular Assist Devices Market Other Major And Innovative Companies

  • LivaNova Plc, Thoratec Corporation, Abiomed Inc, Berlin Heart GmbH, BioVentrix, Cleveland Heart Inc., Jarvik Heart Inc., CorWave SA, SynCardia Systems LLC, NuPulseCV Inc., Fineheart, Procyrion Inc, Carmat SA, BiVACOR Inc, Cardiac Assist Inc.

38. Global Left Ventricular Assist Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Left Ventricular Assist Devices Market

40. Left Ventricular Assist Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Left Ventricular Assist Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Left Ventricular Assist Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Left Ventricular Assist Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer